Medicine & Life Sciences

1. Primary Myelofibrosis 100%
2. Polycythemia Vera 54%
3. Essential Thrombocythemia 53%
4. Mutation 31%
5. Myelodysplastic Syndromes 23%
6. Survival 23%
7. Systemic Mastocytosis 19%
8. Myeloproliferative Disorders 18%
9. Bone Marrow 16%
10. Cytogenetics 15%
11. Leukemia, Myelomonocytic, Chronic 14%
12. Neoplasms 14%
13. Thrombocytosis 13%
14. Acute Myeloid Leukemia 12%
15. Therapeutics 12%
16. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11%
17. Karyotype 11%
18. Anemia 9%
19. Thrombosis 9%
20. Risk Management 8%
21. Imatinib Mesylate 8%
22. Leukemia 8%
23. Splenomegaly 8%
24. Leukemia, Neutrophilic, Chronic 8%
25. Eosinophilia 8%
26. Janus Kinase Inhibitors 7%
27. Chromosome Aberrations 7%
28. Hydroxyurea 7%
29. Polycythemia 7%
30. B-Cell Chronic Lymphocytic Leukemia 6%
31. Platelet Count 6%
32. Splenectomy 6%
33. INCB018424 6%
34. Cladribine 6%
35. Allogeneic Cells 6%
36. Leukocytosis 6%
37. Hemoglobins 6%
38. Janus Kinase 2 5%
39. Stem Cell Transplantation 5%
40. Transplants 5%
41. Megakaryocytes 5%
42. Stem Cells 5%
43. anagrelide 5%
44. Extramedullary Hematopoiesis 5%
45. Mastocytosis 5%
46. Fedratinib 5%
47. Hypereosinophilic Syndrome 5%